Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05346380 · ClinicalTrials.gov registry record · Phase 1
Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery Download
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
NCT05346380: Completed Phase 1 study, sponsored by Massachusetts General Hospital.
NCT05346380 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05346380, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
Study Summary
This will be a prospective, (NSR), single-center feasibility study of the Olympus VE2 NIR Imaging System to assess perfusion using NIR during minimally invasive esophagectomy and pulmonary segmentectomy. The aims of the study are: 1\. To utilize NIR intraoperative imaging with the Olympus VE2 NIR Imaging System to: i. Characterize gastric conduit perfusion during esophagectomy and, ii. Identify segmental anatomy during sublobar pulmonary resection (segmentectomy) after intraoperative, intravenous delivery of low-dose 0.15 mg/kg of ICG.
Interventions
- DRUG Indocyanine green
- DEVICE Olympus VE2 NIR Imaging System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2020-10-29 |
| Est. Completion | 2025-06-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05346380
The ClinicalTrials.gov registry entry for NCT05346380 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indocyanine green is the first listed.
NCT05346380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05346380 about?
NCT05346380 is a clinical study titled "Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery Download". This will be a prospective, (NSR), single-center feasibility study of the Olympus VE2 NIR Imaging System to assess perfusion using NIR during minimally invasive esophagectomy and pulmonary segmentectomy. The aims of the study are: 1\. To utilize NIR intraoperative imaging with the Olympus VE2 NIR I...
What is the current status of trial NCT05346380?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2020-10-29. Estimated completion is 2025-06-03.
What interventions are being tested in trial NCT05346380?
The interventions under investigation include: Indocyanine green (DRUG), Olympus VE2 NIR Imaging System (DEVICE).
Who is sponsoring clinical trial NCT05346380?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.